Grzmil, M.; Imobersteg, S.; Blanc, A.; Frank, S.; Schibli, R.; Béhé, M.P.
Therapeutic Response of CCKBR-Positive Tumors to Combinatory Treatment with Everolimus and the Radiolabeled Minigastrin Analogue [177Lu]Lu-PP-F11N. Pharmaceutics 2021, 13, 2156.
https://doi.org/10.3390/pharmaceutics13122156
AMA Style
Grzmil M, Imobersteg S, Blanc A, Frank S, Schibli R, Béhé MP.
Therapeutic Response of CCKBR-Positive Tumors to Combinatory Treatment with Everolimus and the Radiolabeled Minigastrin Analogue [177Lu]Lu-PP-F11N. Pharmaceutics. 2021; 13(12):2156.
https://doi.org/10.3390/pharmaceutics13122156
Chicago/Turabian Style
Grzmil, Michal, Stefan Imobersteg, Alain Blanc, Stephan Frank, Roger Schibli, and Martin P. Béhé.
2021. "Therapeutic Response of CCKBR-Positive Tumors to Combinatory Treatment with Everolimus and the Radiolabeled Minigastrin Analogue [177Lu]Lu-PP-F11N" Pharmaceutics 13, no. 12: 2156.
https://doi.org/10.3390/pharmaceutics13122156
APA Style
Grzmil, M., Imobersteg, S., Blanc, A., Frank, S., Schibli, R., & Béhé, M. P.
(2021). Therapeutic Response of CCKBR-Positive Tumors to Combinatory Treatment with Everolimus and the Radiolabeled Minigastrin Analogue [177Lu]Lu-PP-F11N. Pharmaceutics, 13(12), 2156.
https://doi.org/10.3390/pharmaceutics13122156